Articles

Poll

Podcasts

Slideshows

Videos

Dermatology

The HCPLive dermatology page is a resource for medical news and expert insights on skin disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for dermatologic conditions, and more.

Icotrokinra outperforms deucravacitinib in achieving skin clearance for plaque psoriasis, offering a promising new oral treatment option.

ICONIC-ADVANCE: Icotrokinra Beats Deucravacitinib for Plaque Psoriasis

Eingun James Song, MD, highlights recent phase 4 data on risankizumab for patients with moderate to severe scalp and genital psoriasis.

Spotlighting New Data on Risankizumab for Scalp and Genital Psoriasis, With Eingun James Song, MD

This letter explores off-label dosing adjustments for patients with psoriasis using the IL-17A inhibitors secukinumab and ixekizumab.

Dose Escalation of IL-17A Inhibitors for Psoriasis Effective, Though Risks Remain

In this study, investigators assessed how the prescription patterns of biologics, non-biologic systemic agents, and phototherapy are altered after cardiovascular events.

Patients with Psoriasis on Biologics More Likely to Continue Use Following MACE

These data underscore the value of individualized cancer risk evaluations when selecting treatment strategies for psoriasis.

Biologic Therapy is Associated with Reduced Risk of Malignancy in Psoriasis

A look at 13 phase 2 and phase 3 studies with significant implications from EADV 2025's late-breaking sessions.

EADV Congress 2025: Late-Breaking Trials Preview

Investigators systematically reviewed NB-UVB treatment responses for psoriasis in patients with skin of color.

Narrowband-UVB Phototherapy Effective for Psoriasis in Skin of Color

In this observational analysis, investigators highlight the potential causal link identified between NHHR and psoriasis development.

Non-High-Density to High Density Lipoprotein Cholesterol Ratio Linked with Psoriasis

An audio recap of the top 5 stories in healthcare news from the week of 08/31-9/5.

HCPLive 5 Stories in Under 5: Week of 08/31

Investigators highlighted the cardiovascular safety of systemic treatments for psoriasis such as methotrexate and tumor necrosis factor inhibitors.

Methotrexate, TNF Inhibitors Are Safest Psoriasis Drugs for Cardiovascular Risk

The HCPLive plaque psoriasis page is a resource for medical news and expert insights on psoriasis. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for psoriatic disease, and more.